EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Safety and Efficacy of TACE-HAIC Combined with Lenvatinib and PD-1 Inhibitors in Large Intermediate-Stage Hepatocellular Carcinoma: A Multi-Center Retrospective Study

Jiayan Ni iD, Chengzhi Li, Hongliang Sun, Yulong Liu, Gefan Guo, Xiong Zhou, Zhiyong Zhou, Rui Fan, Hao Hu, Linfeng Xu iD

Journal of Hepatocellular Carcinoma · 2026-04 · Volume 13 · 1-14

DOI: 10.2147/jhc.s586001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-04. Verfasst von Jiayan Ni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Interventional Radiology, Sun Yat-Sen Memorial …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

hepatic arterial infusion chemotherapyhepatocellular carcinomaimmune checkpoint inhibitortransarterial chemoembolizationtyrosine kinase inhibitor

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Interventional Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of Chin…
  • Department of Interventional Radiology and Vascular Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
  • Department of Interventional Radiology, Shenshan Medical Center, Memorial Hospital of Sun Yat-Sen University, Shanwei, People's Republic of China.
  • Interventional Department, The Fourth People's Hospital of Zigong, Zigong, People's Republic of China.

ORCID-Profile: Jiayan Ni, Linfeng Xu

Zitieren

APA

Ni, J., Li, C., Sun, H., Liu, Y., Guo, G., Zhou, X., Zhou, Z., Fan, R., Hu, H., & Xu, L. (2026). Safety and Efficacy of TACE-HAIC Combined with Lenvatinib and PD-1 Inhibitors in Large Intermediate-Stage Hepatocellular Carcinoma: A Multi-Center Retrospective Study. Journal of Hepatocellular Carcinoma, Volume 13, 1-14. https://doi.org/10.2147/jhc.s586001

Vancouver

Ni J, Li C, Sun H, Liu Y, Guo G, Zhou X, et al. Safety and Efficacy of TACE-HAIC Combined with Lenvatinib and PD-1 Inhibitors in Large Intermediate-Stage Hepatocellular Carcinoma: A Multi-Center Retrospective Study. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-14. doi:10.2147/jhc.s586001

BibTeX
@article{Ni2026,
  author = {Ni, Jiayan and Li, Chengzhi and Sun, Hongliang and Liu, Yulong and Guo, Gefan and Zhou, Xiong and Zhou, Zhiyong and Fan, Rui and Hu, Hao and Xu, Linfeng},
  title = {Safety and Efficacy of TACE-HAIC Combined with Lenvatinib and PD-1 Inhibitors in Large Intermediate-Stage Hepatocellular Carcinoma: A Multi-Center Retrospective Study},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--14},
  doi = {10.2147/jhc.s586001}
}
Kostenlos starten →